Pine Pharmaceuticals Recalls Bevacizumab Syringes Due to Silicone Oil Particulates
Pine Pharmaceuticals is recalling Bevacizumab syringes for intravitreal use because they contain silicone oil microdroplets.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this recall as Class II. According to the severity rubric, an FDA Class II recall involving a drug administered intravitreally (into the eye) is categorized as Severe due to the potential for significant injury or adverse health consequences from particulate matter.
Plain-English summary
Pine Pharmaceuticals, LLC is recalling Bevacizumab 1.25 mg/0.05 mL in 3/10 mL 31 G 5/16" Syringes for intravitreal use. The recall is due to the presence of particulate matter, specifically silicone oil microdroplets, in the syringes.
The affected products were distributed nationwide and in Puerto Rico. The recall covers numerous lots with expiration dates ranging from November 2015 to February 2016. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Healthcare providers and patients should stop using the affected Bevacizumab syringes and contact Pine Pharmaceuticals for further instructions on how to return the product.
The recalled product
- Product
- Bevacizumab 1.25 mg/0.05 mL in 3/10 mL 31 G 5/16" Syringe for intravitreal Rx -- Pine Pharmaceuticals, 100 Colvin Woods Pkwy Suite 300, Tonawanda, NY 14150.
- Manufacturer
- Pine Pharmaceuticals, LLC
- Category
- Drug — Ophthalmic
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot #: 1956@2
- exp. 2/2/2016
- 1954@1
- 1958@3
- 1943@2
- exp. 2/1/2016
- 1942@1
- 1944@3
- 1938@1
- exp. 1/31/2016
- 1939@2
- 1931@1
- exp. 1/28/2016
- 1932@2
- 1935@3
- 1925@1
- exp. 1/27/2016
- 1927@2
- 1928@3
- 1913@3
Distribution
Part of a larger recall action
This product is one of 4 recalled by Pine Pharmaceuticals, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Pine Pharmaceuticals, LLC
See all →- HighFDA Recalls Compounded Moxifloxacin Syringes for Lack of Sterility Assurance
FDA (Drugs) · 2023-10-25
- HighTPC Drops Ophthalmic Solution Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-10-25
- HighFoscarnet Sodium Injectable Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-25
- HighLidocaine eye drops recalled due to lack of sterility assurance
FDA (Drugs) · 2023-10-25
- HighEndophth Kit Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-25
Same hazard · particulate matter
See all →- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- CriticalAmerican Regent Recalls Papaverine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Nitroglycerin Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Cyanocobalamin Injections Due to Particulate Matter
FDA (Drugs) · 2026-08-26